Business Context and Reporting Period
Company: Biote Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: April 3, 2026
Reporting Period: Single event date (April 3, 2026)
Business Context: The filing serves as a Regulation FD disclosure to announce the release of an updated Investor Presentation dated April 2026. The presentation is available on the company's Investor Relations website and is attached as Exhibit 99.1.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding the availability of an investor presentation rather than a financial statement or earnings report.
Material Changes
No material changes to financial performance or operations are detailed in the text of this filing. The only reported event is the public posting of the April 2026 Investor Presentation.
Guidance, Outlook, and Risks
Management Commentary: The filing incorporates the Investor Presentation by reference but explicitly states that the information contained in Item 7.01 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. Consequently, it is not subject to the liabilities of that section nor incorporated by reference into other filings unless expressly stated.
Risks and Contingencies: The filing includes a standard disclaimer that the report does not constitute an admission as to the materiality of any information contained in the attached presentation.
Investor Verification Checklist
- Verify the content of the April 2026 Investor Presentation (Exhibit 99.1) directly on the Biote Corp. Investor Relations website.
- Confirm that the presentation contains forward-looking statements and review the associated risk factors within that document, as they are not detailed in this 8-K.
- Note that the information in this filing is not legally "filed" under Section 18 of the Exchange Act, limiting liability exposure for the content of the presentation.